Loading…
Fertilisers And Chemicals Travancore Ltd
NSE: FACT BSE: 590024 INE188A01015 Commodities Chemicals 🔎 Screen
NIFTY 500 Smallcap 250
₹54,315 Cr
Market Cap
2,974.0
P/E
141.62
PEG
4.9%
ROCE
-2.9%
ROE
2.95
D/E
1.3%
OPM
-20.7%
% from 52W High
37
α RS
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
Shareholding
About

Fertilizers & Chemicals Travancore Ltd (FACT), incorporated in the year 1943, is the first large-scale fertiliser plant in India at Udyogamandal, Kochi, Kerala. The company is engaged in the manufacturing and selling of fertilizers, its by-products and Caprolactam. It is under the administrative control of the Department of Fertilizers, Ministry of Chemicals & Fertilizers, Government of India.

✓ Strengths 1
  • Company is expected to give good quarter
! Concerns 5
  • Stock is trading at 40.2 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 11.9% over past five years.
  • Company has a low return on equity of 8.76% over last 3 years.
  • Earnings include an other income of Rs.176 Cr.
Key Ratios Snapshot
📊 Sector Averages
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
📉 WEAK Revenue up 41% but profit crashes 96% YoY; high leverage a concern
Revenue
Revenue rose 40.9% YoY to ₹1,483.8 Cr, but declined 5.4% sequentially from Dec 2025, hinting at seasonal slowdown or demand moderation.
Profitability
Net profit plunged 95.5% YoY to just ₹3.2 Cr, with EPS falling to ₹0.05 from ₹1.09. A high effective tax rate of 46% further squeezed the bottom line, despite a minor QoQ recovery.
Margins
Operating profit margin contracted sharply to 3.28% from 8.05% a year ago, and also dropped ~2.7 pp sequentially, indicating cost pressures or lower realizations despite revenue growth.
Cash Flow
No cash flow data provided; unable to assess operating cash flow quality relative to reported profit.
Balance Sheet
Total borrowings stood high at ₹3,985 Cr against reserves of ₹703 Cr, resulting in a debt-to-equity ratio of 2.79. Total assets were ₹5,967 Cr, reflecting significant leverage.
Key Risks
1) High debt with low earnings cover poses solvency risk if margins remain thin. 2) Severe margin compression despite revenue growth suggests structural cost issues. 3) Low ROE of 1.61% and stratospheric PE of 2,974 indicate overvaluation relative to earnings.
Outlook
Sustained revenue growth is critical to service debt, but persistent margin pressure and high interest costs may constrain profitability. The company needs to address cost structure and leverage to improve fundamentals.
Generated by AI · Mar 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Documents.

Access concall transcripts, annual reports, credit ratings, and investor presentations.

Upgrade to PremiumCreate Free Account

Revenue by Segment

Segment Q2FY26 Q3FY26 Trend
Fertiliser
1,628
EBIT 46
1,566
EBIT -39
Petrochemical
0
EBIT -13
0
EBIT -13
Total 1,628 1,567

Source: NSE Integrated Filing XBRL (Reg. 33 Ind AS). Values in ₹ Crore.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.